Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

NCT06141473 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1655

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Frexalimab
DRUG: Teriflunomide
DRUG: Placebo infusion
DRUG: Placebo tablet
DRUG: MRI contrast-enhancing agents
DRUG: Cholestyramine
DRUG: Activated charcoal

Sponsor

Sanofi